Page 123 - 83_02
P. 123
36. Ware BR, Berger DR, Khetani SR. Prediction of Drug- 49. Tolosa L, Gómez-Lechón MJ, Jiménez N, et al.
Induced Liver Injury in Micropatterned Co-cultures Advantageous use of HepaRG cells for the screening
Containing iPSC-Derived Human Hepatocytes. and mechanistic study of drug-induced steatosis.
Toxicol Sci 2015; 145: 252-62. Toxicol Appl Pharmacol 2016; 302: 1-9.
37. Tolosa L, Gómez-Lechón MJ, Donato MT. High- 50. Tolosa L, Pinto S, Donato MT, et al. Development of a
content screening technology for studying drug- multiparametric cell-based protocol to screen and
induced hepatotoxicity in cell models. Arch Toxicol classify the hepatotoxicity potential of drugs. Toxicol
2015; 89:1007-22. Sci 2012; 127: 187-98.
38. Chen M, Zhang M, Borlak J, et al. A decade of 51. Gustafsson F, Foster AJ, Sarda S, et al. A correlation
toxicogenomic research and its contribution to between the in vitro drug toxicity of drugs to cell lines
toxicological science. Toxicol Sci 2012;.130:.217-28. that express human P450s and their propensity to
cause liver injury in humans. Toxicol Sci 2014; 137:
39. Wilmes A, Limonciel A, Aschauer L, et al. 189-211.
Application of integrated transcriptomic, proteomic
and metabolomic profiling for the delineation of 52. Donato MT, Jover R, Gómez-Lechón MJ. Hepatic cell
mechanisms of drug induced cell stress. J Proteomics lines for drug hepatotoxicity testing: limitations and
2013; 79: 180-94. strategies to upgrade their metabolic competence by
gene engineering. Curr Drug Metab 2013; 14: 946-68.
40. Cho YE, Moon PG, Baek MC. An integrated
proteomic and transcriptomic approach to 53. Gómez-Lechón MJ, Tolosa L, Donato MT. Upgrading
understanding azathioprine- induced hepatotoxicity in HepG2 cells with adenoviral vectors that encode drug-
rat primary hepatocytes. Electrophoresis 2014; 35: metabolizing enzymes: application for drug
911-22. hepatotoxicity testing. Expert Opin Drug Metab
Toxicol 2017; 13: 137-48.
41. Benet M, Moya M, Donato MT, et al. A simple
transcriptomic signature able to predict drug-induced 54. Kwon SJ, Lee DW, Shah DA, et al. High-throughput
hepatic steatosis. Arch Toxicol 2014; 88: 967-82. and combinatorial gene expression on a chip for
metabolism-induced toxicology screening. Nat
42. García-Cañaveras JC, Jiménez N, Gómez-Lechón MJ, Commun 2014; 5: 3739.
et al. LC-MS untargeted metabolomic analysis of
drug-induced hepatotoxicity in HepG2 cells. 55. Cosgrove BD, King BM, Hasan MA, et al. Synergistic
Electrophoresis 2015 Jun 1. doi: drug-cytokine induction of hepatocellular death as an
10.1002/elps.201500095. in vitro approach for the study of inflammation-
associated idiosyncratic drug hepatotoxicity. Toxicol
43. Donato MT, López-Riera M, Castell JV, et al. Both Appl Pharmacol 2009; 237: 317-30.
cholestatic and steatotic drugs trigger extensive
alterations in the mRNA level of biliary transporters in 56. Kostadinova R, Boess F, Applegate D, et al. A long-
rat hepatocytes: Application to develop new predictive term three dimensional liver co-culture system for
biomarkers for early drug development. Toxicol Lett improved prediction of clinically relevant drug-
2016; 263: 58-67. induced hepatotoxicity. Toxicol Appl Pharmacol
2013; 268:1-16.
44. León Z, García-Cañaveras JC, Donato MT, et al.
Mammalian cell metabolomics: experimental design 57. Kondo Y, Iwao T, Nakamura K, et al. An efficient
and sample preparation. Electrophoresis 2013; 34: method for differentiation of human induced
2762-75. pluripotent stem cells into hepatocyte-like cells
retaining drug metabolizing activity. Drug Metab
45. García-Cañaveras JC, Castell JV, Donato MT, et al. A Pharmacokinet 2014; 29: 237-43.
metabolomics cell-based approach for anticipating and
investigating drug-induced liver injury. Sci Rep 2016; 58. Kia R, Sison RL, Heslop J, et al. Stem cell-derived
6: 27239. hepatocytes as a predictive model for drug-induced
liver injury: are we there yet? Br J Clin Pharmacol
46. Giuliano KA, Gough AH, Taylor DL, et al. Early 2013; 75: 885-96.
safety assessment using cellular systems biology
yields insights into mechanisms of action. J Biomol 59. Gao X, Liu Y. A transcriptomic study suggesting
Screen 2010; 15: 783-97. human iPSC-derived hepatocytes potentially offer a
better in vitro model of hepatotoxicity than most
47. Tolosa L, Gómez-Lechón MJ, Donato MT. High- hepatoma cell lines. Cell Biol Toxicol 2017 Jan 31.
content screening technology for studying drug- doi: 10.1007/s10565-017-9383-z.
induced hepatotoxicity in cell models. Arch Toxicol
2015; 89: 1007-22. 60. Medine CN, Lucendo-Villarin B, Storck C, et al.
Developing high-fidelity hepatotoxicity models from
48. Tolosa L, Gómez-Lechón MJ, Pérez-Cataldo G, et al. pluripotent stem cells. Stem Cells Transl Med 2013; 2:
HepG2 cells simultaneously expressing five P450 505-9.
enzymes for the screening of hepatotoxicity:
identification of bioactivable drugs and the potential 283
mechanism of toxicity involved. Arch Toxicol 2013;
87: 1115-27.
@Real Academia Nacional de Farmacia. Spain
